Log in or Sign up for Free to view tailored content for your specialty!
COPD News
COPD exacerbations heighten risk for severe cardiovascular events, death across countries
Across four countries, the risk for a severe cardiovascular event or death was high 1 to 6 months after a moderate COPD exacerbation, according to a poster presented at the European Respiratory Society International Congress.
Cell therapy shows promise for improving gas exchange in COPD, may offer potential cure
Patients with COPD who underwent autologous transplantation of lung progenitor cells had improved gas exchange capacity, quality of life and walking distance, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants orphan drug designation to inhaled therapy for alpha-1 antitrypsin deficiency
The FDA granted orphan drug designation for KB408 for the treatment of alpha-1 antitrypsin deficiency, according to a press release from Krystal Biotech.
Exposure to more green spaces during pregnancy positively impacts infant birth weight
Pregnant women who lived near forests and parks had reduced odds for low birth weight, which may also decrease the risk for poor infant lung health, according to a presentation at the European Respiratory Society International Congress.
Active screening of patients with diabetes or COPD doubled new diagnoses of heart disease
In a new study, a diagnostic strategy utilizing tools readily available in primary care successfully identified new diagnoses of atrial fibrillation, CAD and HF among patients with type 2 diabetes or chronic obstructive pulmonary disease.
2-year telerehabilitation lowers hospitalization, ED visits in patients with COPD
Telerehabilitation and unsupervised remote training for COPD over 2 years resulted in fewer hospitalizations and ED visits vs. standard care, according to results published in American Journal of Respiratory and Critical Care Medicine.
Inhaler combination outperforms others in reducing COPD exacerbation, cardiovascular risks
Glycopyrronium/indacaterol reduced the likelihood for severe acute exacerbations and cardiovascular events compared with tiotropium/olodaterol among patients with COPD, according to study results published in CHEST.
FDA sends warning to AstraZeneca on misleading COPD therapy promotional communications
Due to misleading claims in a sales aid for Breztri Aerosphere, a triple inhaled therapy for COPD, the FDA has issued a warning letter to its manufacturer, AstraZeneca.
Retraining may prevent asthma, COPD patients’ inhaler technique from getting worse
Inhaler technique deteriorates within 12 months of clinical instruction among patients with asthma and COPD, according to a review published in The Journal of Allergy and Clinical Immunology: In Practice.
Social isolation, loneliness common in adults with COPD
Among adults aged 50 years and older, those with COPD experienced social isolation and loneliness more frequently than those without COPD, according to results published in Annals of the American Thoracic Society.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read